(Q44351744)

2 December 2017

Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze (English)

1 reference

2 December 2017

1 reference

1 reference

1

1 reference

2 December 2017

3

1 reference

2 December 2017

Soosaar A

2

1 reference

2 December 2017

Volke V

4

1 reference

2 December 2017

Ustav M

5

1 reference

2 December 2017

Männistö PT

6

1 reference

2 December 2017

Bourin M

7

1 reference

2 December 2017

Vasar E

8

1 reference

2 December 2017

1 June 1998

1 reference

2 December 2017

1 reference

2 December 2017

32

1 reference

2 December 2017

3

1 reference

2 December 2017

235-240

1 reference

Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous system

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Two brain cholecystokinin receptors: implications for behavioral actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Involvement of the opioid system in the anxiolytic effect of diazepam in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Cholecystokinin antianalgesia: safety cues abolish morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2898%2990042-7

7 January 2021

10.1016/S0143-4179(98)90042-7

Identifiers

DOI

1 reference

2 December 2017

1 reference